Literature DB >> 10498487

An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group.

M Ho1, E R Chen, K H Hsu, S J Twu, K T Chen, S F Tsai, J R Wang, S R Shih.   

Abstract

BACKGROUND: Enteroviruses can cause outbreaks of hand-foot-and-mouth disease (characterized by vesicular lesions on the hands, feet, and oral mucosa) or herpangina, usually without life-threatening manifestations. In 1998 an epidemic of enterovirus 71 infection caused hand-foot-and-mouth disease and herpangina in thousands of people in Taiwan, some of whom died.
METHODS: We assessed the epidemiologic aspects of this outbreak. Cases of hand-foot-and-mouth disease or herpangina in ambulatory patients were reported to the Taiwan Department of Health by a mean of 818 sentinel physicians. Severe cases in hospitalized patients were reported by 40 medical centers and regional hospitals. Viruses were isolated by 10 hospital laboratories and the department of health.
RESULTS: The sentinel physicians reported 129,106 cases of hand-foot-and-mouth disease or herpangina in two waves of the epidemic, which probably represents less than 10 percent of the estimated total number of cases. There were 405 patients with severe disease, most of whom were five years old or younger; severe disease was seen in all regions of the island. Complications included encephalitis, aseptic meningitis, pulmonary edema or hemorrhage, acute flaccid paralysis, and myocarditis. Seventy-eight patients died, 71 of whom (91 percent) were five years of age or younger. Of the patients who died, 65 (83 percent) had pulmonary edema or pulmonary hemorrhage. Among patients from whom a virus was isolated, enterovirus 71 was present in 48.7 percent of outpatients with uncomplicated hand-foot-and-mouth disease or herpangina, 75 percent of hospitalized patients who survived, and 92 percent of patients who died.
CONCLUSIONS: Although several enteroviruses were circulating in Taiwan during the 1998 epidemic, enterovirus 71 infection was associated with most of the serious clinical manifestations and with nearly all the deaths. Most of those who died were young, and the majority died of pulmonary edema and pulmonary hemorrhage.

Entities:  

Mesh:

Year:  1999        PMID: 10498487     DOI: 10.1056/NEJM199909233411301

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  458 in total

1.  An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China.

Authors:  Yan Zhang; Zhen Zhu; Weizhong Yang; Jun Ren; Xiaojuan Tan; Yu Wang; Naiying Mao; Songtao Xu; Shuangli Zhu; Aili Cui; Yong Zhang; Dongmei Yan; Qun Li; Xiaoping Dong; Jing Zhang; Yueping Zhao; Junfeng Wan; Zijian Feng; Junling Sun; Shiwen Wang; Dexin Li; Wenbo Xu
Journal:  Virol J       Date:  2010-05-12       Impact factor: 4.099

2.  Forecasting the economic value of an Enterovirus 71 (EV71) vaccine.

Authors:  Bruce Y Lee; Angela R Wateska; Rachel R Bailey; Julie H Y Tai; Kristina M Bacon; Kenneth J Smith
Journal:  Vaccine       Date:  2010-10-16       Impact factor: 3.641

3.  Direct detection of enterovirus 71 (EV71) in clinical specimens from a hand, foot, and mouth disease outbreak in Singapore by reverse transcription-PCR with universal enterovirus and EV71-specific primers.

Authors:  Sunita Singh; Vincent T K Chow; M C Phoon; K P Chan; Chit Laa Poh
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

4.  Prolonged exclusive breastfeeding, autumn birth and increased gestational age are associated with lower risk of fever in children with hand, foot, and mouth disease.

Authors:  Q Zhu; Y Li; N Li; Q Han; Z Liu; Z Li; J Qiu; G Zhang; F Li; N Tian
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-26       Impact factor: 3.267

5.  Development of a transcription-reverse transcription concerted reaction method for specific detection of human enterovirus 71 from clinical specimens.

Authors:  Naoto Nakajima; Yuka Kitamori; Satoru Ohnaka; Yasutami Mitoma; Katsumi Mizuta; Takaji Wakita; Hiroyuki Shimizu; Minetaro Arita
Journal:  J Clin Microbiol       Date:  2012-02-22       Impact factor: 5.948

6.  A comparison of the biological characteristics of EV71 C4 subtypes from different epidemic strains.

Authors:  Li-chun Wang; Song-qing Tang; Yan-mei Li; Hong-lin Zhao; Cheng-hong Dong; Ping-fang Cui; Shao-hui Ma; Yun Liao; Long-ding Liu; Qi-han Li
Journal:  Virol Sin       Date:  2010-04-09       Impact factor: 4.327

7.  Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.

Authors:  Shiyang Sun; Liping Jiang; Zhenglun Liang; Qunying Mao; Weiheng Su; Huafei Zhang; Xiaojun Li; Jun Jin; Lin Xu; Dandan Zhao; Peihu Fan; Dong An; Ping Yang; Jingcai Lu; Xiuping Lv; Bo Sun; Fei Xu; Wei Kong; Chunlai Jiang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

8.  Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene.

Authors:  Kok Keng Tee; Tommy Tsan-Yuk Lam; Yoke Fun Chan; Jon M Bible; Adeeba Kamarulzaman; C Y William Tong; Yutaka Takebe; Oliver G Pybus
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

9.  Identification of genes involved in the host response to enterovirus 71 infection.

Authors:  Shin-Ru Shih; Victor Stollar; Jing-Yi Lin; Shih-Cheng Chang; Guang-Wu Chen; Mei-Ling Li
Journal:  J Neurovirol       Date:  2004-10       Impact factor: 2.643

10.  A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection.

Authors:  Ya-Fang Wang; Chun-Ting Chou; Huan-Yao Lei; Ching-Chuan Liu; Shih-Min Wang; Jing-Jou Yan; Ih-Jen Su; Jen-Reng Wang; Trai-Ming Yeh; Shun-Hua Chen; Chun-Keung Yu
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.